CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 25 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $838,458 | +4.0% | 54,129 | -21.5% | 0.01% | -14.3% |
Q3 2023 | $806,470 | -18.5% | 68,988 | -6.3% | 0.01% | -12.5% |
Q2 2023 | $989,372 | -5.4% | 73,614 | +16.7% | 0.01% | -11.1% |
Q1 2023 | $1,045,585 | +154.7% | 63,063 | +185.7% | 0.01% | +125.0% |
Q4 2022 | $410,558 | +161.5% | 22,073 | +80.9% | 0.00% | +300.0% |
Q3 2022 | $157,000 | +166.1% | 12,202 | -51.3% | 0.00% | – |
Q1 2018 | $59,000 | -35.2% | 25,067 | +6.6% | 0.00% | – |
Q4 2017 | $91,000 | +33.8% | 23,516 | -13.7% | 0.00% | – |
Q3 2017 | $68,000 | -8.1% | 27,244 | +0.1% | 0.00% | – |
Q2 2017 | $74,000 | +51.0% | 27,226 | +9.0% | 0.00% | – |
Q1 2017 | $49,000 | +122.7% | 24,984 | +17.1% | 0.00% | – |
Q4 2016 | $22,000 | -4.3% | 21,335 | 0.0% | 0.00% | – |
Q3 2016 | $23,000 | +53.3% | 21,335 | -1.2% | 0.00% | – |
Q2 2016 | $15,000 | -44.4% | 21,595 | -7.5% | 0.00% | – |
Q1 2016 | $27,000 | -62.5% | 23,355 | -19.9% | 0.00% | – |
Q4 2015 | $72,000 | +22.0% | 29,144 | +49.6% | 0.00% | – |
Q3 2015 | $59,000 | -28.0% | 19,479 | -2.1% | 0.00% | – |
Q2 2015 | $82,000 | +67.3% | 19,896 | +75.2% | 0.00% | – |
Q1 2015 | $49,000 | +8.9% | 11,355 | -36.0% | 0.00% | – |
Q2 2014 | $45,000 | +2.3% | 17,744 | -9.1% | 0.00% | – |
Q1 2014 | $44,000 | +51.7% | 19,518 | +29.4% | 0.00% | – |
Q4 2013 | $29,000 | -32.6% | 15,082 | +6.3% | 0.00% | – |
Q3 2013 | $43,000 | +290.9% | 14,187 | +15.3% | 0.00% | – |
Q2 2013 | $11,000 | – | 12,304 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 17,875,655 | $94,920,000 | 9.39% |
TANAKA CAPITAL MANAGEMENT INC | 283,334 | $1,505,000 | 4.86% |
GABLES CAPITAL MANAGEMENT INC. | 490,564 | $2,606,000 | 1.84% |
MANGROVE PARTNERS IM, LLC | 2,508,838 | $13,322,000 | 1.61% |
Broadfin Capital, LLC | 880,303 | $4,674,000 | 0.86% |
Atom Investors LP | 1,012,355 | $5,376,000 | 0.37% |
Capital Impact Advisors, LLC | 179,868 | $948,000 | 0.36% |
KNOTT DAVID M | 151,415 | $804,000 | 0.34% |
EMERALD ADVISERS, LLC | 1,175,958 | $6,244,000 | 0.29% |
CADENCE CAPITAL MANAGEMENT LLC | 371,075 | $1,970,000 | 0.28% |